In the murine model, it was demonstrated that pro-inflammatory cytokines and chemokines are essential to the formation and modulation of Schistosomainduced granulomatous inflammation. However, the relationship of these immune mediators and disease severity is hard to be established in naturally infected individuals. The current study evaluates the association between plasma concentrations of MIF, sTNF-R1, CCL3, CCL7 and CCL24 and schistosomiasis morbidity in Schistosoma mansoni-infected patients with a low parasite burden. For this propose, 97 S. mansoni-infected individuals were subjected to abdominal ultrasound analysis and clinical examination. Among them, 88 had plasma concentration of immune mediators estimated by ELISA assay. Multivariate linear regression models were used to evaluate the relationship between the plasma concentration of immune mediators and the variables investigated. Although most individuals presented low parasite burden, over 30% of them showed signs of fibrosis defined by ultrasound measurements and 2 patients had a severe form of schistosomiasis. No association between parasite burden and the plasma levels of chemokine/cytokines or disease severity was observed. There was a positive association between plasma concentration of CCL4, sTNF-R1, CCL3 and MIF with gall bladder thickness and/or with portal vein thickness that are liver fibrosis markers. In contrast, no association was found between CCL7 plasma concentrations with any of the schistosomiasis morbidity parameters evaluated. The data showed that CCL24, sTNFR1, MIF and CCL3 can be detected in plasma of S. mansoni-infected individuals and their concentration would be used as prognostic makers of Schistosoma-induced liver fibrosis, even in individuals with low parasite burden.
Abstract
In the murine model, it was demonstrated that pro-inflammatory cytokines and chemokines are essential to the formation and modulation of Schistosomainduced granulomatous inflammation. However, the relationship of these immune mediators and disease severity is hard to be established in naturally infected individuals. The current study evaluates the association between plasma concentrations of MIF, sTNF-R1, CCL3, CCL7 and CCL24 and schistosomiasis morbidity in Schistosoma mansoni-infected patients with a low parasite burden. For this propose, 97 S. mansoni-infected individuals were subjected to abdominal ultrasound analysis and clinical examination. Among them, 88 had plasma concentration of immune mediators estimated by ELISA assay. Multivariate linear regression models were used to evaluate the relationship between the plasma concentration of immune mediators and the variables investigated. Although most individuals presented low parasite burden, over 30% of them showed signs of fibrosis defined by ultrasound measurements and 2 patients had a severe form of schistosomiasis. No association between parasite burden and the plasma levels of chemokine/cytokines or disease severity was observed. There was a positive association between plasma concentration of CCL4, sTNF-R1, CCL3 and MIF with gall bladder thickness and/or with portal vein thickness that are liver fibrosis markers. In contrast, no association was found between CCL7 plasma concentrations with any of the schistosomiasis morbidity parameters evaluated. The data showed that CCL24, sTNFR1, MIF and CCL3 can be detected in plasma of S. mansoni-infected individuals and their concentration would be used as prognostic makers of Schistosoma-induced liver fibrosis, even in individuals with low parasite burden.
| INTRODUCTION
Human schistosomiasis is a chronic and debilitating infection caused by trematodes of the Schistosoma genus. The condition affects over 240 million people in 78 countries of tropical and subtropical areas, particularly in sub-Saharan Africa, where close to 800 million people are at risk of contracting the disease. [1] [2] [3] During the chronic phase of intestinal schistosomiasis, disease morbidity has been associated mostly with the type and intensity of the granulomatous inflammatory response induced by egg-secreting antigens that become trapped in venules in the host's tissues, especially in the liver and intestine. 4, 5 Granuloma formation and modulation are dynamic processes that lead to the sequential recruitment and accumulation of immune cells around the trapped Schistosoma egg, mediated by a local production of immune mediators, such as cytokines and chemokines. [6] [7] [8] The granuloma induced by parasite eggs causes the confinement of the parasite antigens, thereby protecting the host tissue from their cytotoxic effect. Moreover, the granulomatous inflammation helps to eliminate the eggs through the intestine mucosae and promote host tissue remodelling. 9 However, excessive and unregulated granulomatous inflammation with intense extracellular matrix deposition leads to severe hepatosplenic schistosomiasis, which is characterized by periportal fibrosis, portal hypertension, gastrointestinal bleeding and death. 5, 10, 11 In Schistosoma-infected mice, the immune response induced by interleukin-4 receptors (IL-4Ra) activation is necessary to prevent hepatotoxicity and host acute mortality. 9, 12, 13 Interleukin (IL)-13 is the main pro-fibrotic mediator, and its production and regulation are associated with fibrosis severity in infected animals. 14 Moreover, modulation of the host immune response, mediated mainly by IL-10 production, is essential to reduce morbidity and increases the host's survival in the chronic phase of the experimental infection. 15, 16 In agreement with experimental data, studies in Schistosoma-infected populations have shown that circulating leucocytes obtained from patients presenting severe schistosomiasis produced elevated levels of IL-5 and IL-13, 17,18 whereas patients with low levels of fibrosis had higher concentrations of IFN-gamma and IL-10. 19, 20 However, identifying the association between immune response and liver damage/fibrosis is challenging as many cytokines have a short half-life, and therefore, their serum and plasma levels are difficult to measure. 21 In the last decades, many studies have shown that tissue injury leads to the production of innate cytokines and chemokines that orchestrate cell activation, differentiation and trafficking to the injury site. 22, 23 Moreover, several reports implicated chemokines in the pathophysiology of inflammatory and infectious diseases, including atopic dermatitis, asthma, atherosclerosis, multiple sclerosis, rheumatoid arthritis and Chagas disease. 23, 24 These immune mediators and/or their soluble receptor are easily detectable in circulation and have been used as biomarkers or prognostic tools of disease severity. 25 Similarly, many published work [6] [7] [8] [26] [27] [28] [29] showed that innate cytokines and chemokines induced by antigens from Schistosoma eggs trapped in the host's tissue orchestrate granuloma formation and modulation in mouse models. Moreover, previous data from our group revealed that MIP-1a/CCL3 production or activation of CCR5, a G protein-coupled receptor, responsible for some of CCL3 effects, interferes with granuloma formation and, consequently, affected the disease severity in S. mansoni-infected mice. [30] [31] [32] In contrast to experimental model, the role of these immune mediators in human schistosomiasis is scarce and the published research so far has been mostly performed with patients harbouring a large parasite burden and/or severe pathology. 20, 30, 33 As a consequence of frequent use of schistosomiasis treatment of severely infected individuals in Brazil and many other endemic areas in the world, most of the infected patients present low parasite burden and contribute to environment contamination, allowing frequent re-infection of the exposed population. In this new epidemiologic scenery, the characterization of the immune response of these patients, especially in the case of chemokines and innate cytokines, and their association with schistosomiasis morbidity is warranted. Moreover, soluble concentration of these mediators would be useful as biomarkers of disease severity.
Using multivariate regression linear analysis, this study searched for possible associations between plasma concentrations of macrophage migration inhibitory factor (MIF), soluble TNF-a receptor 1 (sTNF-R1) and the chemokines MIP-1a (macrophage inflammatory protein-1a)/CCL3, MCP-3 (monocyte chemoattractant protein-3)/CCL7 and eotaxin-2/CCL24 with schistosomiasis-related morbidity in S. mansoni-infected patients living in a rural community of an endemic area of the Minas Gerais state, Brazil. Our data indicate that plasma concentrations of MIF, sTNFR1, CCL24 and CCL3, but not CCL7, are positively associated with S. mansoni-induced liver fibrosis in patients with low parasite burden.
| PATIENTS AND METHODS

| Ethical considerations
This study was approved by the Ethics Committee of the Federal University of Minas Gerais, Brazil (under protocol number 274/05). Prior to the commencement of the research activities, the participants and/or their legal guardians were informed about the study and signed a consent form. Regardless of taking part in the study, patients with confirmed parasite infection received the necessary treatment for schistosomiasis, and patients with other diseases were either treated or directed to specialized treatment.
| Study population
The original study aimed to evaluate schistosomiasis morbidity in high endemic area of Brazil. 34 For this proposal, the authors evaluated, parasitological and clinically, 741 inhabitants 5 years of age or older from rural communities of Jequitinhonha Valley, in the north-eastern area of the Brazilian state of Minas Gerais and revealed a prevalence rate of schistosomiasis of 73%. The area had no reported cases of malaria and the individuals were sero-negative for Leishmania infection, at the time of sample collection and clinical evaluation. 34 The current work used plasma samples, parasitological and clinical data of S. mansoniinfected individuals residents on rural communities of C orrego do Choro, in Padre Para ıso city, one of the areas of the original study. From this locality, we selected all S. mansoni-infected patients ageing between 14 and 68 years old at the time of sample collection that had been submitted to clinical and ultrasound evaluation and had frozen plasma sample to estimate the concentration of immune mediators by ELISA assay. Plasma samples from 8 noninfected donors were used as controls. The population used in current study was the same used for evaluate the humoral response. 35 
| Data collection
The methodology employed for data collection has been previously described in Ref. 34 In brief, each participant answered a structured questionnaire to reveal their socioeconomic background and clinical history associated with schistosomiasis. Blood and faeces samples were also collected. Schistosoma mansoni infection parasitological confirmation was determined by the egg count from smears obtained from 2 thick stool samples using the Kato-Katz technique. 36 Further, each infected individual was submitted to a clinical and abdominal ultrasound (US) examination performed by 2 independent experts, which have no knowledge of any other parameter evaluate. The clinical examination included a general physical evaluation and medical history annotation. Abdominal palpation was performed on the dorsal decubitus position on a deep breath by 2 experienced physicians. The liver and spleen were considered palpable when the liver and spleen borders were felt below the costal margins by both examiners. Abdominal US scans were performed using an EUB 200 US equipment (Hitachi, Japan) with an electronic linear 3.5-MHz transducer. 34, 37 During US examination, the examiner measured the liver, the spleen, the diameter and wall thickness of the portal vein at the hilo and its secondary branches, and the gallbladder. US measurements were analysed as continuous and categorized values obtained after height adjustment according to the Niamey protocol. 38, 39 The following parameters were considered for the categorization: spleen's longitudinal dimension (<120 and ≥120 mm); left (<85 and ≥85 mm) and right (median <90 and ≥90 mm) liver lobes' longitudinal dimensions; portal vein diameter (<11 and ≥11 mm) and wall thickness (≤5 and >5 mm); thickness of the portal vein's secondary branches (≤4 and >4 mm); and gallbladder wall thickness (≤3 and >3 mm).
Of the 97 infected individuals selected for the study, only 88 generated enough plasma sample to quantify inflammatory cytokines and chemokines. Plasma concentrations of MIF, sTNF-R1, CCL3, CCL7 and CCL24 were determined using a sandwich enzyme-linked immunosorbent assay (ELISA) kit, according to the manufacturer's instructions (R&D Systems, USA). Plasma concentration of sTNFR1 was used to detect receptor activation as its circulating concentration directly correlates with production of TNF-a. 40, 41 For chemokine analysis, first, the plasma samples were thawed and larger proteins were removed by acid/salt precipitation. 42 Briefly, an equal volume of plasma and 1.2%
trifluoroacetic acid/1.35 mol/L NaCl solution was mixed and left at room temperature for 10 minutes. Then, samples were centrifuged for 5 minutes at 3000 g, and the supernatants, containing only small sized proteins, were used for chemokine quantification. For the assay, the final plasma dilution was 1:10 in phosphate buffer (0.14 mol/L sodium chloride and 0.01 mol/L sodium phosphate at pH 7.4). All samples were assayed in duplicate on the same day.
| Statistical analysis
Databases were generated using EPI-INFO version 6.04, and statistical analyses were performed using STATA version 11.0 software (Stata Corporation, 2010). Normal distribution of data was verified using the Shapiro-Wilk test. The Mann-Whitney test was used for the comparisons of medians, and the means were compared using Student's t test or analysis of variance (ANOVA) following by Neuman-Keuls post-test. Additionally, one-tailed nonparametric Spearman correlation analyses were used to evaluate possible associations among the cytokine/chemokine concentrations evaluated. Linear regression analyses were used to evaluate the relationship between the plasma concentration of each chemokine/cytokine or its soluble receptor and the co-variables under investigation (demographic, clinical, ultrasound measurements and parasite burden). Variables with P values <.25 were selected to construct the multivariable linear regression models, and US measurements were used only as continuous values for the final model. Furthermore, variables with low frequency presenting co-linearity were excluded from the multivariable analyses. Full models for each cytokine/chemokine or its soluble receptor were constructed with all the independent variables selected for univariate analysis, and modelling was carried out through a backward process. The only variables remaining in the final model were those that were statistically significant assuming a 95% confidence interval (CI) with differences presenting a P-value under .05. Results are reported as linear regression parameter estimates, along with 95% CI for the effect of independent variables for the cytokine of interest. Homoscedasticity of the final models were also evaluated.
RODRIGUES OLIVEIRA ET AL.
| Study population characteristics
The 97 S. mansoni-infected individuals studied herein resided at the rural community of C orrego do Choro, located in the Jequitinhonha Valley in northern Minas Gerais State, Brazil. They were the same individuals previously evaluated in a study investigating humoral immune response and schistosomiasis morbidity. 35 The individuals analysed had between 14 and 68 years of age, with a median age of 30 years old (IQR 26). There was no significant gender difference as 51.5% were females and 48.5% were males. Thirty-two individuals (33%) reported being previously treated for schistosomiasis, indicating a high re-infection rate in the area. The infected population was characterized by low parasite burden, with a median of 36 eggs/g faeces. In this study population, no significant difference was observed between parasite burden and gender or age group. There was also no difference in parasite burden between infected individuals that had previously been treated with anti-Schistosoma (re-infected) and non-treated individuals. 35 
| Clinical and abdominal ultrasound evaluation
Although the S. mansoni-infected individuals presented low parasite burden, clinical examination revealed that some of them had severe schistosomiasis symptoms: 7 had hematemesis; 50 had a palpable liver during clinical examination ( Figure 1A ) with 10 of them displaying a rigid liver consistency and 4 presenting a rough liver border; 9 had a palpable spleen ( Figure 1B ) with 4 displaying a hard spleen consistency and 2 presenting collateral abdominal circulation ( Figure 1C ). There was no statistically significant difference in the number of eggs found per gram of faeces between infected individuals presenting clinical signs of severe schistosomiasis and those displaying none ( Figure 1A -C).
Abdominal US examination of the S. mansoni-infected individuals showed that only 4 patients had longitudinal spleen sections larger than 120 mm ( Figure 1D ), and 70 had longitudinal sections of the left liver lobe larger than 85 mm ( Figure 1F ). Interestingly, 4 subjects had right liver lobe sections smaller than 90 mm ( Figure 1E ), which is considered abnormal for the sample population. 38, 39 However, spleen and liver US measurements had no significant association with parasite burden (Figure 1D-F) . The US measurements of portal vein and gallbladder thickness and/or diameter were used as indicators of liver fibrosis. A total of 32 S. mansoni-infected individuals presented increased portal vein diameters ( Figure 1G ), 31
showed thick secondary branches of their portal vein (Figure 1H) , and 39 individuals had increased gallbladder wall thickness ( Figure 1I ). Although all patients had low parasite burden, 2 had classical hepatosplenic (HS) schistosomiasis symptoms (characterized by the presence of abdominal collateral veins, palpable and rigid liver and spleen at clinical examination, enlarged liver and spleen with thickness of portal vein and gallbladder wall demonstrated by US examination) and over 30% had signs of periportal and/or perivesicular fibrosis according to US data. However, there was no significant association between parasite burden and the parameters of liver fibrosis measured by abdominal US (Figure 1G-I ).
3.3 | Plasma cytokine and chemokine concentrations in Schistosoma-infected individuals Table 1 shows the plasma concentrations of sTNF-R1 and MIF, CCL3, CCL7 and CCL24 detected in samples from S. mansoni-infected individuals living in the studied area (Corrego do Choro) and from non-infected volunteers from non-endemic areas (Table 1) .
Plasma concentrations of sTNF-R1, MIF and CCL24 were significantly higher in S. mansoni-infected than in non-infected individuals. A few infected individuals had elevated CCL3 plasma levels, but no significant difference was observed between infected and non-infected individuals in the study population. There was also no statistically significant difference in the plasma concentrations of CCL7 between S. mansoni-infected and non-infected individuals (Table 1) . Possible associations of plasma concentration among the inflammatory mediator measured were evaluated in the infected population. There was a positive correlation between CCL3 and sTNF-R1 plasma concentrations in this population (R 2 = .216, P = .033), but no other associations were found between the plasma concentration of the cytokines, soluble cytokine receptor and chemokines evaluated herein.
| Relationship between the plasma
concentrations of cytokines/chemokines, parasite burden and demographic parameters of S. mansoni-infected individuals Linear regression analysis did not detect any association between the plasma levels of MIF, sTNF-R1, CCL3, CCL7 and CCL24, and the number of parasite eggs eliminated per gram of faeces by the S. mansoni-infected individuals (Figure 2) . Because association between the plasma concentrations of CCL7 and sTNFR1 with parasite burden resulted in a P-value lower than .1 ( Figure 2B,D) , the variables were included in the multivariate analysis. No associations were detected between plasma concentrations of MIF, CCL3 and CCL24 with gender, age and water contact amongst the infected individuals (data not shown). Interestingly, plasma concentrations of CCL7 and sTNF-R1 were significantly higher in infected males than in females (CCL7 32 vs 62, P = .013; sTNFR1 674 vs 792, P = .012); therefore, the final multivariate analysis was adjusted by age and gender.
3.5 | Relationship between the plasma concentrations of cytokines or chemokines and schistosomiasis' morbidity parameters Possible relationship between plasma concentrations of sTNF-R1, MIF, CCL3, CCL7 and CCL24 and schistosomiasis' morbidity parameters were assessed by clinical examination and abdominal US measurements taken from S. mansoni-infected individuals. There was no significant difference in plasma concentrations of MIF, CCL3, CCL7 and CCL24 between asymptomatic S. mansoni-infected and the infected individuals that shown typical symptoms of schistosomiasis during clinical examination, specifically, palpable liver and/or spleen (data not shown). In contrast, TNFR1 plasma levels were significantly higher in infected individuals presenting severe schistosomiasis clinical symptoms (patients with collateral veins, palpable liver and spleen with hard consistencies) in comparison with infected individuals with no visible clinical alterations; specifically, the median concentration of sTNFR1 in HS schistosomiasis was 1074 pg/mL (interquartile range 1053, 1094; n = 2) compared to 772 pg/mL in infected individuals with no liver or spleen clinical alteration (interquartile range 596, 952; n = 43; P = .024). However, the number of infected individuals showing these symptoms was low, only 2 : spleen longitudinal size (D); right liver lobe size (E); left liver lobe size (F); portal vein diameter (G) and thickness (H); and gall bladder wall thickness (I). Each point represents measurements obtained from one individual. The horizontal line represents the median value for each group. P-values were calculated by the Mann-Whitney test, and statistically significant differences were assessed assuming a 95% confidence interval infected individuals. Therefore, these clinical parameters were not included in the multivariate analysis.
The US measurements showed positive associations between the plasma concentrations of MIF ( Figure 3A ,B), sTNFR1 ( Figure 3C ,D) and CCL24 ( Figure 3E,F) with the thickness of secondary branches of the portal vein. For MIF and sTNFR1, the positive association between the plasma concentration of each inflammatory mediator and the thickness of the portal vein wall was detected when the values were analysed as both continuous and categorized variables.
Plasma concentrations of sTNF-R1 ( Figure 4A ,B), CCL-3 ( Figure 4C,D) and CCL-24 ( Figure 4E ,F) were also positively associated with gallbladder wall thickness, another important marker of Schistosoma-induced fibrosis. There were no associations between the plasma concentrations of the cytokines and chemokines evaluated herein and the US measurements of liver or spleen sizes. Moreover, CCL7 plasma levels in S. mansoni-infected individuals showed no association with any of the US measurements evaluated in the current study. Tables 2 and 3 present the final linear regression models that describe the effect of US parameters of schistosomiasis morbidity on the plasma concentrations of each inflammatory mediators evaluated in this study, adjusted by parasitological (parasite load and treatment) and demographic (age and gender) data. The analysis showed that high plasma concentrations of MIF in S. mansoni-infected individuals were positively and independently associated with the wall thickness of the portal vein's secondary branches (Table 2) . Moreover, the plasma levels of sTNFR1 were positively associated with the thickness of the portal vein and the gallbladder walls and inversely associated with schistosomiasis treatment (Table 2) .
| Multivariable linear regression models
Fibrosis-related thickening of the gallbladder wall was also positively associated with the plasma levels of the chemokines CCL3 and CCL24. In addition, high plasma levels of CCL24 in S. mansoni-infected individuals were positively associated with thick portal vein branches walls (Table 3 ).
| DISCUSSION
This cross-sectional study searched for a possible association between the plasma concentrations of MIF, sTNFR1, CCL3, CCL7 and CCL24 and schistosomiasis' morbidity parameters in S. mansoni-infected subjects presenting a low parasite burden. S. mansoni-endemic areas with low parasite burden are representative of most parasite transmission areas in Brazil and other regions of the world subjected to frequent schistosomiasis treatment as the main strategy of disease control. Diagnosis and treatment of schistosomiasis cases in these areas is often challenging because of the small number of eggs eliminated in the host's faeces, favouring parasite transmission and frequent re-infection of individuals. 43 Although there was an expressive reduction in number of severe S. mansoni-induced hepatosplenic disease and deaths in these endemic areas, 43 abdominal US scans identified liver and circulatory damage, such as periportal fibrosis, in Schistosoma-infected individuals harbouring low parasite load, 44 a finding that should be further investigated.
In the current study, we identified only 2 patients with signs of hepatosplenic schistosomiasis. Nevertheless, over 30% of the infected individuals showed some degree of liver fibrosis, observed mainly as a thickening of secondary branches of the portal vein and gallbladder walls. As reported by a previous work using the same population of infected individuals, 35 there was no association between parasite burden and schistosomiasis severity in these endemic areas. The results support the hypothesis that parasite burden is not the sole factor defining schistosomiasis severity 5, 45 and allow us to better understand the relationship of immune response on the disease morbidity parameters, such as liver fibrosis, in naturally infected population. Moreover, in this new scenario of schistosomiasis transmission (characterized by low parasite burden and frequent reinfection), the identification of easily detectable circulating biomarkers associated with disease prognosis would help the correct diagnosis and treatment of infected individuals. Experimental models of schistosomiasis showed that local production of immune mediators, such as cytokines, determines the severity status of the disease. [6] [7] [8] However, because cytokines are locally produced and rapidly catabolized, their quantification in serum/plasma samples is difficult. 21, 46 Most studies aiming to characterize the immune response in Schistosoma-infected individuals measured cytokine concentration in peripheral blood mononuclear cells (PBMC) after in vitro re-stimulation with parasite antigens. [17] [18] [19] [20] In the current study, we evaluated circulating levels of chemokines and soluble cytokine receptors, which are molecules more stable 8, 29 in Schistosoma-infected individuals. The results obtained using this approach showed that the plasma concentrations of sTNF-R1, MIF, CCL3, CCL7 and CCL24, immune mediators that were previously associated with schistosomiasis severity in experimental model, were not positively associated with parasite burden or with the US measurements of liver and spleen size of infected individuals evaluated in the current study. However, the plasma concentrations of MIF, sTNF-R1, CCL3 and CCL24 were associated with wall thickening of secondary branches of the portal vein and/or gallbladder, some markers of Schistosoma-induced liver fibrosis. It is important to mention that some parameters presented wider CI (Tables 2 and 3) , probably due to infection status of the participants (low parasite burden) and small number of individuals evaluated. Migration inhibitory factor production was previously associated with macrophage and lymphocyte activation in Th1- 47 and Th2-mediated chronic inflammatory diseases. [48] [49] [50] In some Th2-inflammatory diseases, MIF promotes F I G U R E 2 Relationship between the plasma concentrations of cytokines and parasite burden in Schistosoma mansoni-infected individuals.
Plasma concentrations of MIF (A) sTNFR1, (B) CCL3, (C) CCL7 (D) and CCL24 (E) in S. mansoni-infected subjects (n = 88) were estimated by ELISA. Parasite burden was estimated as the number of S. mansoni eggs per gram of faeces, according to Kato-Katz's method. 36 The association between each cytokine and the parasite burden was evaluated by linear regression and P value plotted. MIF, migration inhibitory factor; sTNFR1, soluble tumour necrosis factor receptor 1; CCL3, C-C motif chemokine ligand 3; CCL7, C-C motif chemokine ligand 7; CCL24, C-C motif chemokine ligand 24.
eosinophil migration and activation, contributing with the disease severity. 49, 50 In S. mansoni-infected mice, there are increased MIF production during granuloma formation. 51 Moreover, MIF-deficient mice showed reduced eosinophil recruitment in Schistosoma-induced liver granulomas, which were smaller and presented less cellularity than the granulomas formed by their wild-type counterparts. 52 A pro-fibrotic effect of MIF was demonstrated in experimental models of OVA-induced eosinophilic esophagitis, 50 ConA-induced hepatic fibrosis 53 and OVA-induced asthma. 54 In the carbon tetrachloride (CCl4)-induced liver fibrosis model, female MIF-deficient mice showed reduced leucocyte recruitment, especially inflammatory macrophages, a significant reduction in HSC activation and synthesis of collagen 1a1 mRNA during the initial response. 55 Similar process could be important in S. mansoni-induced liver fibrosis, as the recruitment of pro-inflammatory cells, including monocytes/macrophages, has been associated with the differentiation of local hepatic stellate cells (HSC) into myofibroblasts that contribute to collagen production. 11 The current study is the first to implicate MIF in human schistosomiasis and the first to assign a putative role for MIF in S. mansoni-induced liver fibrosis. Taken together, these data suggest that plasma concentration of MIF could be a biomarker of Schistosoma-induced fibrosis. TNF-a is a potent pro-inflammatory cytokine, which participate in Schistosoma-induced granulomatous inflammation and egg-laying in murine models of schistosomiasis. 56 Moreover, mice with severe schistosomiasis maintain elevated levels of TNF-a in the liver at chronic phase of the infection, whereas milder cases present reduction in TNF-a, 57 indicating that TNF-a would participate in the morbidity status of experimental schistosomiasis. Studies performed with human populations from Schistosoma-endemic areas showed that the circulating concentrations of TNF-a are low or undetectable in most individuals and are not associated with Schistosoma infection or disease severity. 58 In contrast, Schistosoma-mediated TNF-a production by PBMC from infected individuals correlated with clinical manifestations of hepatosplenomegaly or severe fibrosis post-age and gender adjustment. 17, 20, [59] [60] [61] Thus, although TNF-a production had the potential to be a biomarker of schistosomiasis severity, its serum concentration was not an accurate predictor. To minimize this, the current work estimated TNF-a activity indirectly by measuring the plasma concentration of its soluble receptor sTNFR1. Previous reports showed that binding of TNF-a to its receptors, TNFR1 or TNFR2, leads to the shedding of the receptor. The soluble forms of the receptors are easier to detect in blood because of its longer half-life compared to TNF-a. 62 Our results revealed higher levels of sTNFR1 in plasma of S. mansoni-infected individuals compared to uninfected controls. The multivariate analysis performed herein found that sTNFR1 plasma concentration is positively correlated with liver fibrosis and negatively correlated with anti-Schistosoma treatment. In the studied population that has low parasite burden, this relationship was independent of the parasite burden, age and gender.
Our data improve the current understanding about the direct role of the TNF-a/TNFR1 activation pathway in S. mansoni-induced liver fibrosis. A direct participation of TNF-a in liver fibrogenesis induced by Schistosoma infection and other chronic liver diseases leading to fibrosis has been previously described. A polymorphism at position À308 in the promoter region of the TNF-a gene has been associated with an increase in TNF-a expression and the risk of hepatic fibrosis in some liver pathologies. 63 A study carried out in Schistosomainfected Sudanese individuals showed that high levels of TNF-a were associated with increased risk of periportal fibrosis. However, there was no detectable influence of the TNF-a G308A polymorphism in the status of fibrosis severity. 64 In vitro data suggested that fibrotic effect of TNF-a in liver could have the participation of HSC. Primary cultures of HSCs from wild-type, TNFR1 knockout, . Plasma concentrations of sTNFR1 (A, B), CCL3 (C, D) and CCL24 (E, F) were assessed by ELISA. Continuous values were analysed by a linear regression test, and the categorized values were analysed by the Mann-Whitney test. P-values < 0.05 were considered significant and the value was plotted. sTNFR1, soluble tumour necrosis factor receptor 1; CCL3, C-C motif chemokine ligand 3; CCL24, C-C motif chemokine ligand 24 TNFR2 knockout or TNFR1/R2 double knockout (TNFR-DKO) mice treated with TNF-a indicated that loss of TNFR1 or TNFR1/R2, but not TNFR2, reduced pro-Collagen-a1 expression and MMP-9 induction, slowed down HSC proliferation and impaired PDGF-induced pro-mitogenic signalling. 62 Comparable results were observed in the human HSC cell line LX-2. 62 These data indicate a fibrogenic role for TNFa/TNFR1 pathway in HSC, which could be happening in Schistosoma-induced fibrosis.
Various experimental studies suggested an essential role of chemokines in the sequential recruitment of cells to Schistosoma-induced granulomas. 8, 29, 65 Zimmermann et al 66 and Chensue et al 65 showed that IL-4 and/or IL-13 induce the production of CCR3 ligands such as the MCP chemokine family (CCL2, CCL7) and eotaxins (CCL11, CCL24). CCR3 ligands are involved in the recruitment of eosinophils, basophils and some lymphocyte subsets. These, in turn, amplify Th-2 polarization and could be important factors in Schistosoma-induced granuloma formation and disease severity. In experimental models of pulmonary granuloma formation, local production of CCL7 was essential for eosinophil infiltration. 67, 68 Moreover, the livers of Schistosoma japonicum-infected mice showed increased the expression of CCL7 after 6 weeks of infection, which correlated to increases in alternatively activated macrophage markers and fibrosis-associated genes. CCL7 expression was identified in fibrotic areas of the granuloma, where activated HSCs were also found. 6 Although CCL7 had been previously associated with granuloma formation in experimental Schistosoma models, the plasma levels of CCL7 in S. mansoni-infected individuals evaluated herein did not correlate with the parasite burden or the morbidity parameters analysed. This difference between experimental model and infected population would be related to the Schistosoma specie and host tissue (lung vs liver).
In this study, we also show that S. mansoni-infected individuals present significantly higher CCL24 plasma levels than uninfected volunteers. In addition, periportal or perivesicular wall thickness suggests a role for CCL24 in Schistosoma-induced hepatic fibrosis. Only 2 studies to date have reported increased levels of CCL24 in Schistosoma-infected individuals 69, 70 and none investigated the association between CCL24 and morbidity. The roles of CCL24 and CCL3 in eosinophil recruitment and activation have been well established in experimental models of schistosomiasis. 6, 8, 65 Activated eosinophils are important sources of the potent pro-fibrotic cytokines IL-13 and TGF-b, 71, 72 which might be involved in S. mansoniinduced liver fibrosis. In addition to its role in eosinophil chemotaxis, CCL24 promotes human lung fibroblast proliferation and collagen synthesis. 73 In line with this rationale are the findings of Isgr o et al 74 suggesting that CCL5, CCL11 and CCL24 contribute to airway recruitment of fibrocytes and airway obstruction in severe asthma patients. Finally, the role of CCL3 in granuloma formation and schistosomiasis severity has been well documented in experimental murine infections. Intravenous injections of S. mansoni eggs in CCR1-deficient animals 75 showed reduced pulmonary granulomas. Recently, we reported that S. mansoni infection in CCL3-deficient mice resulted in smaller liver granulomas, lower eosinophil recruitment/ Previous studies also revealed that high CCL3 concentrations were associated with severe disease Schistosomainfected individuals. 30, 31, 33, 69 The current study corroborates and expands the current understanding regarding CCL3 participation in Schistosoma-induced morbidity. Our data showed that plasma concentrations of CCL3 found in S. mansoni-infected individuals with low parasite burden and no signs of severe schistosomiasis were positively associated with disease morbidity, more specifically with S. mansoni-induced liver fibrosis.
In bleomycin (BLM)-induced pulmonary fibrosis, CCL3 participates in macrophage and fibroblast recruitment to the lungs, and TNF-b induction leading to collagen deposition and lung fibrosis. 76 Recently, Russo et al 77 reported a significant reduction in TNF-a and TGF-b in the lungs and attenuated lung fibrosis in BLM-inoculated mice treated with evasin-1, a tick-derived chemokine-binding protein that has high affinity for CCL3. Interestingly, we found a positive correlation between the plasma levels of CCL3 and sTNFR1 in S. mansoni-infected individuals. In addition to its effect on macrophages and fibroblasts, CCL3 also participates in lymphocyte recruitment and type-2 cytokine production, such as IL-13, which has a pro-fibrotic function following Schistosoma infection. 30, 78 Taken together, the data reported herein indicate that the plasma concentrations of CCL24, sTNFR1, MIF and CCL3 associate with liver fibrosis and may play a role in the pathogenesis of human schistosomiasis. In addition, measurement of plasma levels of these inflammatory mediators could have prognostic value for liver fibrosis induced by S. mansoni infection even in patients with a low parasite burden and who have not developed the most severe form of the disease.
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